Jeffrey Hatfield

Jeffrey Hatfield

Fortune : 379 749 $ au 31/05/2026

68 ans
Health Technology
Commercial Services
Consumer Services

Profil

Jeffrey S.
Hatfield
is currently Chairman at Vividion Therapeutics, Inc. since 2023, Independent Chairman at Vir Biotechnology, Inc. starting in 2026, Chairman at Rome Therapeutics, Inc. since 2022, and Director at Gate Bioscience, Inc. beginning in 2024.
Former roles include President, Chief Executive Officer & Director at Vitae Pharmaceuticals LLC from 2011 to 2016; Chief Executive Officer & Director at Zafgen, Inc. from 2017 to 2020; Chief Executive Officer at Larimar Therapeutics, Inc. from 2017 to 2020; Chairman at Viridian Therapeutics, Inc. from 2018 to 2021; Director at Ambit Biosciences Corp.
from 2014 to 2015; Independent Director at aTyr Pharma, Inc. from 2017 to 2021; Director at Biotechnology Innovation Organization from 2011 to 2016; Director at InVivo Therapeutics Corp.; Independent Director at Invivo Therapeutics Holdings Corp.
from 2016 to 2018; Senior VP-Virology & Immunology Divisions at Bristol Myers Squibb Co. from 2000 to 2004; Vice President at Managed Health Care Associates, Inc.; President & General Manager at Bristol Myers International Group; and President at The Bristol-Myers Squibb Canada Co. Education includes undergraduate studies at Purdue University and an MBA from The Wharton School of the University of Pennsylvania.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
27/05/2026 39 806 ( 0,02 % ) 379 749 $ 31/05/2026

Postes actifs de Jeffrey Hatfield

SociétésPosteDébut
VIR BIOTECHNOLOGY, INC. Président 26/05/2026
Président 18/07/2022
Président 24/01/2023
Directeur/Membre du Conseil 01/08/2024

Anciens postes connus de Jeffrey Hatfield

SociétésPosteFin
VIRIDIAN THERAPEUTICS, INC. Président 01/06/2021
ATYR PHARMA, INC. Directeur/Membre du Conseil 28/04/2021
LARIMAR THERAPEUTICS, INC. Directeur Général 01/05/2020
LARIMAR THERAPEUTICS, INC. Directeur Général 01/05/2020
INVIVO THERAPEUTICS HOLDINGS CORP. Directeur/Membre du Conseil 31/12/2018
Voir l'expérience en détail de Jeffrey Hatfield

Formation de Jeffrey Hatfield

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

89

Relations au 1er degré

19

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées19

Health Technology

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Consumer Services

Health Technology

Bristol Myers International Group

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

  1. Bourse
  2. Insiders
  3. Jeffrey Hatfield
🔇